High levels of ammonia in tumors lead to fewer T cells and immunotherapy resistance in mouse models of colorectal cancer, new findings from the University of Michigan Rogel Cancer Center revealed.
DTX301, an investigational AAV8 gene therapy, significantly reduced 24-hour plasma ammonia levels in patients with late-onset ornithine transcarbamylase deficiency. Topline data were announced from a ...
Add Yahoo as a preferred source to see more of our stories on Google. March 12 (Reuters) - Ultragenyx Pharmaceutical said on Thursday its experimental gene therapy helped patients in a late-stage ...
Pig and poultry organisations have hit back at attempts by green lobby groups to denigrate their sectors based on ammonia ...
March 12 (Reuters) - Ultragenyx Pharmaceutical said on Thursday its experimental gene therapy helped patients in a late-stage trial to better control ammonia levels linked to a rare inherited disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results